Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Oxford Endovascular are developing a novel treatment for treating brain aneurysms.
Proxisense has developed extreme environment proximity sensors and fluid contamination systems.
Building the most advanced global infrastructure for People Science.
OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.
QuantrolOx is building automated machine learning-based control software for quantum technologies to tune, stabilize, and optimize qubits.
Beacon Therapeutics is a biotechnology company that develops treatments to preserve and restore vision for rare and prevalent eye diseases.
Genomics plc aiming to lead the genomic transformation of healthcare.
Neu Health enables clinicians, caregivers, and patients to tackle this growing challenge with cutting-edge digital technologies.
Oxford Flow is able to save money without sacrificing performance.
ONI is a pioneer of super-resolution microscopy, making this advanced technology accessible to new generations of researchers.
A med-tech startup that has developed a passive and contactless device for monitoring nocturnal symptoms and environmental metrics at home.
Alethiomics is a biotech company harnessing the power of single-cell multi-omic technology to discover & develop treatment for blood cancer.
BehaVR develops evidence-based, immersive, digital therapeutics for behavioral health using Virtual Reality.
Lab-quality diagnostics for anyone, anywhere, at any time.
Xerion Healthcare is the technology commercialization company of University of Oxford.
Analytics to maximise environmental and social investment returns
Animal Dynamics Ltd, based in Oxford, UK, is a technology company specialising in the design and manufacture of autonomous vehicles.
Kesmalea Therapeutics is a biotech startup focusing on the discovery of novel protein degraders.
Allos is a solution to prognose, monitor, and treat autoimmune conditions.
Perspectum provides imaging solutions to help doctors in clinical decision-making as well as support patient engagement.
Scripta Therapeutics operates as a bio-tech company.
Kneu Health transforms smart phones into clinical-grade monitors to keep a tab on neurological conditions like Parkinson’s and dementia.
Living Optics is an imaging technology company.
Oath Surgical operates with distinction, offering our patients, associates, and partners unmatched value and experiences.
Oxford Science Enterprises has invested in 134 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Oxford Science Enterprises's top investment sectors include Health Care, Biotechnology, Medical, Life Science, Therapeutics. The firm invests across 49 different industry categories.
Among tracked funding rounds, Osler Diagnostics received $85.0M in a Series C round. Oxford Science Enterprises's total known invested capital is $2.2B.
Oxford Science Enterprises's average investment size is $18.0M across its portfolio of 134 companies.
Recent Oxford Science Enterprises portfolio additions include Oxford Endovascular, Proxisense, Prolific, OMass Therapeutics, Quantrol Ox. These companies were founded in 2020 or later.